Sending Office: Honorable J. Luis Correa
Original Cosponsors: Rep. J. Luis Correa (D-CA), Rep. Clay Higgins (R-LA)
Current Cosponsors (75):
Takano, Brownley, Aguilar, Blumenauer, Brindisi, Carbajal, Cardenas, Cisneros, Cohen, Crist, Crow, Dean, DeFazio, DeGette, DelBene, Escobar, Eshoo, Espaillat, Gabbard,
Gaetz, Gallego, Chuy Garcia, Grijalva, Haaland, Hastings, Hayes, Heck, Higgins, Hill, Himes, Horsford, Huffman, Hank Johnson,
Jones, Kennedy, Khanna, Kim, Peter King, Kuster, Lamb, Barbara Lee, Lofgren, Lujan, Luria, Sean Patrick Maloney, McCollum, Meeks, Meng, Moulton, Norton, Omar, Panetta, Pappas, Perlmutter, Peters, Pingree, Pocan, Porter, Quigley, Raskin,
Rice, Rose, Rouda, Roybal-Allard, Ruiz, Rush, Schakowsky, Adam Smith, Soto, Swalwell, Titus,
Waltz, Watson Coleman, Welch, Yarmuth, Young
Supported By: AMVETS, Iraq and Afghanistan Veterans of America (IAVA), Veterans of Foreign Wars (VFW), Disabled American Veterans (DAV), Paralyzed Veterans of America (PVA),
Wounded Warrior Project, Veterans Cannabis Coalition, Fleet Reserve Association,
American Psychological Association, MedMen, Americans for Safe Access, Multidisciplinary Association for Psychedelic Studies (MAPS), Students for Sensible Drug Policy, NCIA, NORML, Blinded Veterans Association
According to an Iraq and Afghanistan Veterans of America survey, 83 percent of their membership agree that cannabis should be legal for medical purposes while 90 percent support medical cannabis research. Therefore, medical research into the safety and efficacy
of cannabis usage for medical purposes is timely, necessary, and widely supported by the veteran community.
As many veterans are currently using cannabis for medicinal purposes, it is important that clinicians be able to fully advise veterans on the potential impacts, harms, and benefits of cannabis use on post-traumatic stress disorder (PTSD) and chronic pain.
The VA Medicinal Cannabis Research Act of 2019 requires research into the safety and efficacy of medicinal cannabis usage on veterans diagnosed with PTSD and chronic pain. The VA Medicinal Cannabis Research Act of 2019 is a pragmatic and bipartisan piece
of legislation that would advance our understanding of the impacts of medicinal cannabis usage and could improve the lives of veterans and other Americans.
The VA Medicinal Cannabis Research Act of 2019 would direct VA to conduct clinical research with varying forms of medicinal cannabis to evaluate the safety and effects of cannabis on health outcomes of veterans with PTSD and veterans with chronic pain.
Section by Section
Sec. 1: Short Title.
“VA Medicinal Cannabis Research Act of 2019”
Sec. 2: Department of Veterans Affairs Clinical Trial of the Effects of Cannabis on Certain Health Outcomes of Adults with Chronic Pain and Post-Traumatic Stress Disorder
This section would:
- require VA to conduct a double-blind clinical trial on cannabis, in various forms and delivery methods, on specified health outcomes of veterans with PTSD and veterans with chronic pain;
- authorize a long-term observational study of participating veterans;
- require VA to preserve all data collected or used for the purposes of conducting future research related to medicinal cannabis;
- require VA to submit annual reports to Congress on the implementation of this bill for five years.
Thank you for your consideration of this request. Please contact Emilio Mendez at
Emilio.Mendez@mail.house.gov with Rep. Correa or Kelsey Wolfgram at
Kelsey.Wolfgram@mail.house.gov with Rep. Higgins with any questions or to cosponsor this bipartisan bill.
J. Luis Correa Clay Higgins
Member of Congress Member of Congress
e-Dear Colleague version 2.0